Intestinal Effect of the Probiotic Escherichia Coli Strain Nissle 1917 and Its Omv Publisher



Behrouzi A^{1, 2} ; Mazaheri H⁴ ; Falsafi S⁵ ; Tavassol ZH^{1, 2} ; Moshiri A^{6, 7} ; Siadat SD^{1, 2, 3} Show Affiliations
Source: Journal of Diabetes and Metabolic Disorders Published:2020

Abstract

Several investigations have been conducted during the past years to examine the correlation between dysbiosis and both intestinal and extra-intestinal diseases such as inflammatory bowel disease (IBD) and ulcerative colitis (UC).E. coli Nissle 1917 (EcN) is a nonpathogenic gram-negative strain utilized in numerous gastrointestinal issues, consisting of diarrhea, uncomplicated diverticular malady, IBD and specifically UC. Many investigations have been done to examine the capability of assertive bacteria, inclusive of commensal and probiotic strains to enhance IBD in clinical testing. Bacterial secreted factors have been investigated to detect the EcN agents that facilitate the regulation of tight junction. These agents candiffuse smoothly through the mucin layer before reaching intestinal epithelial cells. Outer membrane vesicles (OMVs) are known as intercellular communicasomes as they facilitate the distal transfer of active compounds between cells. A few investigations have detailed immune-modulatory attributes for EcN through various systems that could be liable for its clinical viability in IBD. Today, the function of gut microbiota extracellular vesicles in health and disease has become a focus of attention as they serve as vehicles for the transmission of microorganisms to distal tissues of many bacterial effectors. © 2020, Springer Nature Switzerland AG.